{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPmEl78KDA","lastupdate":"2025-09-10T00:00:00.000Z","update_date":"2025-09-10T00:00:00.000Z","lastModified":"Sep 10, 2025","active":1,"confidence_score":100,"confidence_score_reason":"markets","urlname":"neurokaire","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$X7rjz3qqbnCzXoxbvFdtpiwGamNYWXTRw9VVnTtRruIvnNwl9Ayo9h.jpeg","name":"NeuroKaire ","oneliner":"Precision Medicine for Psychiatry and Neurology","registrar":"515897205","website":"https://www.neurokaire.com","careerspage":"https://www.genetikaplus.com/jobs","founded_month":8,"founded_year":2018,"formernames":["Genetika+","GENETIKA RX"],"sociallinks":{"twitter":"https://twitter.com/Genetikaplus","youtube":"https://www.youtube.com/channel/UCPrzpeKog5qfli5T6faeSTw","facebook":"https://www.facebook.com/genetikaplus","linkedin":"https://www.linkedin.com/company/28148811","instagram":""},"social":["https://www.facebook.com/genetikaplus","https://www.youtube.com/channel/UCPrzpeKog5qfli5T6faeSTw","https://www.linkedin.com/company/28148811","https://twitter.com/Genetikaplus"],"flattenedsociallinks":"https://www.facebook.com/genetikaplus|https://www.youtube.com/channel/UCPrzpeKog5qfli5T6faeSTw|https://www.linkedin.com/company/28148811|https://twitter.com/Genetikaplus","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":46,"patent":1,"raised":25270000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["GeneticaPlus","Genetika+","Genetika","Genetika Plus"],"about":"NeuroKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug therapy for their patients. The NeuroKaire test predicts the best drug treatment for each patient, enabling faster treatment, fewer side effects, and lower dosing.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97253219656","country":null,"address":{"israeli":[{"id":"de06260b-a5f4-43f1-9889-d0dfd29bfae1","city":"Tel Aviv-Yafo","type":null,"address":"Yigal Alon St 126, Tel Aviv-Yafo, Israel","placeid":"ChIJwZdje5hLHRURXHC19nWcM64","notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"DnZKlPGuBZKS9AwVceOLhIxTn7aJbO33QWtSeT3b4rIPIZk4mu3VZo","city":"Kearny","address":"78 John Miller Way, Kearny, NJ 07032, USA","country":"United States","placeid":"ChIJhYN5nk9RwokRlMhi3oGA6RM"}]},"headquarter_address":null,"district":"Center District","news":[{"id":"j33JPMJMpEqf17jrWzGpKPI3Oooowlyjrlp2OBHKBV1SLrxW70n0s0","date":"Sep 9, 2025","link":"https://www.calcalistech.com/ctechnews/article/byof9tp9ge","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"innovation","round":null,"company":"NeuroKaire","layoffs":null,"summary":"NeuroKaire, formerly known as Genetika+, has launched BrightKaire, a groundbreaking test that uses AI and stem-cell technology to personalize antidepressant treatment for patients with major depressive disorder (MDD). This innovation, which has received regulatory approval in the U.S., allows for a more accurate and faster determination of effective medication, potentially reducing the trial-and-error period from years to weeks. The company has raised $25 million from venture capital funds and secured additional grants from the European Union. BrightKaire is available in the U.S. and Israel, with tests conducted in the U.S. NeuroKaires approach represents a significant advancement in personalized psychiatry, offering hope for more effective treatment of depression.","partners":null,"customers":null,"eventType":null,"investors":["GreyBird Ventures","Meron Capital","Sapir Venture Partners","Jumpspeed Venture Partners"],"confidence":9,"key_topics":["AI technology","stem-cell","depression","personalization","psychiatry"],"date_of_event":"2022","product_stage":"released","investment_date":"2022","acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$25 million","structured_issues":["Product Stage","Investment","Customers","Partners"],"acquisition_amount":null,"FDA approved/pending approval":"approved","AI technology developing/using":"using","structuredIssuesShow":"#Product Stage  #Investment  #Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Z8xPgu5sZmKvMvDiyba32cBcV6dwdZDpjMsZViXERfiYhIztBEd3Kg","news_summary":"Israeli startup NeuroKaire launches world’s first blood test to personalize depression treatment | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"v1yWpZzxW5qyYVYVVdvpNL1QSPiSmoD0TIZx3jkX1bjCOZh6khwhiI","date":"Dec 17, 2024","link":"https://www.prnewswire.com/il/news-releases/neurokaire-secures-10-million-to-advance-precision-medicine-for-mental-health-302333663.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"precision medicine","company":"NeuroKaire","layoffs":null,"summary":"NeuroKaire, a biotechnology company specializing in precision medicine for psychiatry and neurology, has secured $10 million in funding to advance its clinical test for identifying drug efficacy in depression patients. The funding round was led by GreyBird Ventures, with participation from Meron Capital and Jumpspeed Ventures. This investment will enable NeuroKaire to scale operations, expand its team, and deepen research and development efforts. The company aims to enhance its pharmaceutical partnerships and drive innovation in drug discovery and development. NeuroKaires innovative test provides insights into brain function and drug response, helping clinicians identify the optimal antidepressant for patients. The company is poised to transform treatment paradigms in depression and improve the efficiency of new drug development.","partners":null,"customers":null,"investors":["GreyBird Ventures","Meron Capital","Jumpspeed Ventures"],"confidence":9,"key_topics":["depression","funding","precision medicine","drug efficacy","partnerships"],"date_of_event":"Not explicitly mentioned","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$10 million","structured_issues":["Investment","Partners","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"lawqvQOBrZjOyK6VtNh27E1LblHzvbKaQkVuhorlOzOjXHtrH1AGTS","news_summary":"/PRNewswire/ -- NeuroKaire, a pioneering biotechnology company specializing in precision medicine in psychiatry and neurology, has successfully secured $10...","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"L7I2eb1N2cIwaSFRQZSTxcVLmXDFvip6gjPGGyIMJ7zkPS3OR2qn4P","date":"Feb 6, 2023","link":"https://www.prnewswire.com/il/news-releases/clexio-and-genetika-announce-partnership-using-proprietary-antidepressant-screening-platform-301739377.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"partnership","company":"Clexio","layoffs":null,"summary":"Clexio and Genetika+ are partnering to screen and characterize Clexios antidepressant pipeline using Genetika+s iPSC-derived neurons platform. This partnership allows for the assessment of the functional effects of drugs directly on human neurons, enabling a readout of the antidepressant effect of a candidate drug and the characterization of a compound with respect to its effect on different depression subpopulations. The collaboration aims to contribute to the advancement of personalized medicine for psychiatry. Clexio is a CNS-first clinical stage pharmaceutical company dedicated to developing novel therapies for neurological and psychiatric conditions. Genetika+ is developing personalized medicine solutions for psychiatric and neurological diseases.","partners":["Genetika+"],"customers":null,"investors":null,"confidence":8,"key_topics":["depression","antidepressant pipeline","neurons platform","functional readouts","personalized medicine"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"tU5Ftt7c1wRsE9Q1qiK22leRADSPABHT8SwLXazwxFFZgpfDWDsRg4","news_summary":"Clexio and Genetika+ announce partnership using proprietary antidepressant screening platform","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"JMJZ9eXBHVk5rkhgq3jt0NnfNfEukRGXxATJRO559qiGJYwEJf8BY0","date":"Oct 20, 2022","link":"https://www.medicaldevice-network.com/news/genetika-ce-neurokaire-test/","source":"www.medicaldevice-network.com","visible":1,"analysis":{"tags":"personalized medicine, blood test, depression, AI, machine learning","company":"Genetika+","layoffs":null,"summary":"Genetika+ has obtained a CE-IVD mark for its new blood test, NeuroKaire, which aims to optimize treatment for depression. The AI-powered tool helps physicians determine the optimal antidepressant treatment required for major depressive disorder (MDD) patients. The test has been developed using data collected from MDD patients and leverages advanced AI and machine learning approaches. A multi-site study showed high accuracy in predicting drug response in MDD patients, validating NeuroKaires efficacy. Genetika+ plans to collaborate with hospitals and physicians to launch the tool in regular clinical practice. The CE-IVD mark demonstrates the accuracy and efficacy of NeuroKaire and facilitates its adoption in the European market. MDD is estimated to affect over 300 million people globally.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["NeuroKaire","blood test","depression","AI","machine learning"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"RmaMAwhNNtrdDYT6xRx5Z2ojKTCFodBBi42HQm01itBA1nC6A7DwoY","news_summary":"Genetika+ obtains CE-IVD mark for NeuroKaire blood test","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"JnXB5AbaROXOjnNEaEpFbEDlgnX5Fem74sYr8dHCX4Tl4nhUOZaqDw","date":"Oct 19, 2022","link":"https://www.prnewswire.com/il/news-releases/genetika-announces-ce-mark-for-neurokaire-its-ai-powered-tool-to-optimize-depression-treatment-301653411.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"precision medicine, antidepressant, major depressive disorder","company":"Genetika+","layoffs":null,"summary":"Genetika+ has announced the CE-IVD mark for NeuroKaire, a blood test that predicts drug response in patients with major depressive disorder (MDD). The test is designed to assist physicians in prescribing the optimal antidepressant treatment for MDD patients. Genetika+ is partnering with physicians and hospitals to implement the tool in routine clinical practice. The NeuroKaire test combines AI-driven biomarkers, pharmacogenetics, and clinical data to provide accurate predictions of drug response. The CE mark follows successful results from a multi-site study, validating the efficacy of NeuroKaire. MDD affects over 300 million people globally, and there is a significant unmet need for a product like NeuroKaire to improve treatment outcomes and reduce healthcare costs associated with suboptimal disease management.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["NeuroKaire","precision medicine","major depressive disorder","CE-IVD mark","partnership"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"1qj18D3YNGbrdwHKPpULcfQ32SjtvZIJQoXdXkE5YjM3vkNU65Tbu4","news_summary":"Genetika+ Announces CE Mark for NeuroKaire™ its AI-powered Tool to Optimize Depression Treatment","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a4c73760-1caf-43a9-bbf8-fe053a7991d2","date":"Jul 25, 2022","link":"https://www.businesswire.com/news/home/20220725005850/en/Genetika-Wins-Prestigious-European-Funding-to-Bring-Depression-Drug-Matching-Platform-to-Market","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"WNYDj78RoKLB1Wfd1BBINhxeFfZVagzo4cDxyezvnU0ofIR5DDEu8b","news_summary":"Genetika+ Wins Prestigious European Funding to Bring Depression Drug Matching Platform to Market","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"3ed27639-b7c6-460e-b2d5-af48575296e8","date":"Oct 3, 2021","link":"https://www.prweb.com/releases/genetika_a_pioneer_in_personalized_medicine_for_psychiatry_raises_10_million_in_an_oversubscribed_series_a/prweb18227293.htm","source":"www.prweb.com","visible":1,"analysis":{"tags":["precision medicine","mental health"],"company":"Genetika+","layoffs":null,"summary":"Genetika+ has closed a $10 million Series A funding round led by GreyBird Ventures to develop personalized medicine solutions for psychiatric and neurological diseases. The companys lead solution personalizes antidepressant treatment for each patient using its Brain-in-a-Dish technology. The funding will be used to accelerate the companys next phase, including expanded clinical trials, increased manufacturing capabilities, and establishment of a clinical lab in Boston. Genetika+ plans to hire for multiple positions over the next 12 months to support research and business development activities. Depression affects over 300 million people worldwide, and Genetika+ aims to provide a more effective and personalized approach to medication selection for depression patients.","partners":null,"customers":null,"investors":["GreyBird Ventures","Meron Capital","Jumpspeed Ventures","Sapir Venture Partners","Howard Morgan","Michael Zeisser"],"confidence":9,"key_topics":["personalized medicine","antidepressant treatment","precision medicine","funding","clinical trials"],"date_of_event":"September 30, 2021","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$10 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"hRUUs5MKaQRgRrkW9FSbFVoxuYDPfMYc4Ar0kesNJ2doUL0C5R66ZM","news_summary":"Genetika+ - A Pioneer in Personalized Medicine for Psychiatry - Raises $10 Million in an Oversubscribed Series A","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"476c4656-4354-4de6-8d06-4c7f0e41772e","date":"Jun 22, 2021","link":"https://www.technology-innovators.com/genetika/","source":"www.technology-innovators.com","visible":1,"analysis":{"tags":"biotech, personalized medicine","company":"Genetika+","layoffs":null,"summary":"The article features an interview with Talia Cohen Solal, the CEO & Co-Founder of Genetika+, a biotech start-up specializing in personalized medicine for major depression. Genetika+ uses biological data, genetic testing, and medical history to develop personalized depression treatments for patients. The company aims to eliminate the trial-and-error component of depression treatment by predicting which medication will work for each individual patient. Talia discusses her journey from academia to entrepreneurship, the challenges faced in the industry, and her passion for mental health. The article highlights the potential of healthcare technology to revolutionize personalized and targeted treatments. Talia also mentions the need for more resources and faster development of medical treatments. The impact on the company is growth-positive, as Genetika+ is advancing treatment in the mental health space.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Genetika+","depression treatment","personalized medicine","biotech","healthcare technology"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"sy9QRlpo3RB1T5OESfmMl86u8pVP9fPykDP5R4GmeMlOoD4ikLEZeu","news_summary":"Genetika+: Combating Depression Talia Cohen Solal, CEO & Co-founder, Genetika+","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"54a2c8e5-064b-4c56-a3c9-8357f798732e","date":"Feb 25, 2020","link":"https://networkandchill.club/interview-with-talia-from-genetika/","source":"networkandchill.club","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"QJYxlOXZcEjz3CTQHBJ1qMu8B9dwM8ChxYb4tGPL8uE7upV4i5dTmt","news_summary":"Interview with Talia from Genetika+ - Network & Chill","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"2781d1c5-dfc6-4930-af85-5d643fc442fa","date":"Dec 3, 2019","link":"https://www.directsellingnews.com/avon-products-inc-reveals-winner-of-women-startup-competition/","source":"www.directsellingnews.com","visible":1,"analysis":{"tags":"startup competition","company":"Genetika+","layoffs":null,"summary":"Genetika+ has won Avons Women Startup Competition 2019 with their cutting edge technology for determining the best drug to treat depression for each patient. The start-up from Jerusalem was crowned the winner during the final event in London. The competition brought together nine winners of the local semi-finals and three top start-ups from an online beauty accelerator program. The winners had the opportunity to meet with investors and Avon executives to help grow their business. The judging panel included investors and executives from Avon and Mintel. The competition aims to foster entrepreneurialism among women and encourage innovation that benefits society.","partners":["Avon Products Inc"],"customers":null,"investors":null,"confidence":9,"key_topics":["Genetika+","Avons Women Startup Competition 2019","cutting edge technology","depression treatment","start-up winners"],"date_of_event":"December 03, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"HYhtBQ3e2fT3dZjOSkdUfBHEbAiwQXvJRBEpsU8fBddQ7BZtUa30ry","news_summary":"Avon Products, Inc. Reveals Winner of Women Startup Competition - Direct Selling News","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"94774014-77e9-4ffd-b376-cb90c9e1c3f3","date":"May 10, 2019","link":"https://www.jpost.com/Opinion/Hillels-Tech-Corner-Impact-at-its-best-589285","source":"www.jpost.com","visible":1,"analysis":{"tags":"mental health, personalized medicine","company":"Genetika+","layoffs":null,"summary":"Genetika+ is an Israeli company developing a personalized test to help physicians choose the right drug for each patient suffering from depression. By combining a patients genetic background, patient history, and cell-based screening platform, Genetika+ aims to provide a reliable and accurate prediction of the optimal drug. The company has raised $1.4 million in funding and is conducting a retrospective clinical trial to demonstrate patient outcomes. Genetika+ plans to enter the market in 2021. The founders, Dr. Daphna Laifenfeld and Dr. Talia Cohen Solal, have impressive backgrounds in neuroscience and genetics. They are dedicated to improving the lives of those suffering from major depression and other mental illnesses.","partners":null,"customers":null,"investors":"Meron Capital, Jumpspeed Ventures, Sapir Venture Partners, Howard Morgan, Israel Innovation Authority","confidence":8,"key_topics":["Genetika+","personalized medicine","depression","mental health","Israeli technology"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$1.4 million","structured_issues":["Customers","Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"bLCXIcGA7VnJYJqFU3HzlTUGXZeo7QmvPDpqYA26G2hRAZTAgObLIG","news_summary":"https://www.jpost.com/Opinion/Hillels-Tech-Corner-Impact-at-its-best-589285","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"e229897f-a14f-4643-bde7-0349e4f64b9d","date":"Nov 6, 2018","link":"https://masschallenge.org/media/masschallenge-israel-awards-500000-ILS-cash-prizes-top-startups-boston-2018","source":"masschallenge.org","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"Ea8Me91rjoXgjuTOVelivMRwJD4LiD0JPlhmkd3A4qcOheSs9XnvZq","news_summary":"MassChallenge Israel Awards 500,000 ILS in Cash Prizes to Top Startups in Boston","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":12,"techcommunityinvolvement":null,"mediagallery":[{"id":"58f6cdea-fc34-4ad2-b6fb-fd6baadbbf41","timestamp":"2020-07-13 14:55:17.000000","resources_type":2,"resources_title":"Genetika+","resources_file_name":"7oovQR2j1M8","alt":"Genetika+ logo","imageurl":"https://img.youtube.com/vi/7oovQR2j1M8/0.jpg","url":"http://youtu.be/7oovQR2j1M8"}],"tags":["clinical-trials","neurology","genetic-engineering","pharma-companies","deep-learning","mental-health","machine-learning","digital-healthcare","medication","doctors","personalization","testing","artificial-intelligence","clinics","healthcare-providers","patients","neuroscience","hospitals","psychiatry","decision-support"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[{"id":"UTRB0fIDIS8ZzPE5VqmSLyTE9wxD3cfnkp1cGkL6LZMK5FQb6er9ov","link":"https://www.neurokaire.com/clinicians","name":"NeuroKaire","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T20:58:36.746Z","Revenue Growth":3,"Risk Mitigation":3,"Industry Vertical":"Healthcare","ready_for_display":true,"Talent Development":3,"Agility & Innovation":4,"Customer Acquisition":4,"Operational Efficiency":4,"Short Solution Description":"NeuroKaire offers an AI-powered digital platform for clinicians to remotely monitor, manage, and provide personalized care for patients with neurological conditions, such as Parkinson's disease, by tracking symptoms, medication adherence, and delivering objective insights."}},{"id":"uhovDJsZsUVLW1eK3bZgBVQb95AQ1KLaZfJjpRFHqUbdh8HAGRRToQ","link":"https://www.neurokaire.com/biopharma","name":"StemifAi","ai_analysis":{"Confidence":0.9,"created_at":"2025-07-22T22:59:33.921Z","Revenue Growth":4,"Risk Mitigation":4,"Industry Vertical":"Biopharma","ready_for_display":true,"Talent Development":3,"Agility & Innovation":5,"Customer Acquisition":3,"Operational Efficiency":5,"Short Solution Description":"NeuroKaire's StemifAi is an AI-driven platform designed to accelerate drug discovery and development for neurological disorders, optimizing R&D processes, improving clinical trial success rates, and reducing costs."}}],"businessmodels":["B2B2C","B2B"],"productstage":"Beta","products":[],"geomarkets":["United States","Europe"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":7,"lastfunding":"$10M","totalrounds":7,"fundingstage":"A","totalfunding":"$25.27M","publicinvestors":6,"lastpublicfunding":10000000,"totalpublicrounds":6,"totalpublicfunding":24120000},"team":[{"name":"Talia Cohen Solal","email":"talia@neurokaire.com","phone":"","gender":"Female","userid":"70R03c30L1gPKkVok6AwQBI2DVgXjDtxlTlBGDIG0lrllfCsRm52jY","bounced":false,"claimed":null,"founder":1,"urlname":"talia-cohen-solal","visible":0,"memberid":"ZPvGcWo3nWLAuGE56GCFJf6f04jnzIOlkcj8Uitua9VayIUEHjghJA","position":"Co-founder & CEO","last_name":"Cohen Solal","claimtoken":"Z49ykrMV5g1Gx0WqL4h4KHOfnZ3oBtKrLbNxyhiRHQHBGYle7qXlV6","first_name":"Talia","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/talia-cohen-solal-5b49a78/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2025-01-11 20:36:45.000000","initials":"TC","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>private</text>\n</div>'"},{"name":"Talia Cohen Solal","email":"talia@genetikaplus.com","phone":"0503219656","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoMXs4JwJDA","bounced":false,"claimed":1,"founder":1,"urlname":"talia-cohen-solal-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgxc7RngkM","position":"Founder & CEO","last_name":"Cohen Solal","claimtoken":"2c2adbebea807f7f0c3ff9b08c2586fe0ca38a0683593a0396e554f210614f24","first_name":"Talia","picturekey":"$12v7C6QuXF3bpymMy8eeTFfE3Rys1028TySOLYkh1bx9ezgXta3Ly0","claimeddate":"2018-07-19","linkedinurl":"https://www.linkedin.com/in/talia-cohen-solal-5b49a78","unsubscribed":false,"is_activeuser":1,"additionalemail":"talia.atkin@gmail.com","claimedemaildate":"2018-07-19 08:24:05.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$12v7C6QuXF3bpymMy8eeTFfE3Rys1028TySOLYkh1bx9ezgXta3Ly0","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Daphna Laifenfeld","email":"daphna.laifenfeld@ibex-ai.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoKX0xowJDA","bounced":true,"claimed":0,"founder":1,"urlname":"daphna-laifenfeld","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICgpduOkwkM","position":"Founder & CSO","last_name":"Laifenfeld","claimtoken":"fQOoZgn7MAy3uTtaw7aMmizX1f744R85JM22u26hQm7OPya9Vqbymg","first_name":"Daphna","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/daphna-laifenfeld-959bb91/","unsubscribed":false,"is_activeuser":1,"additionalemail":"daphna@genetikaplus.com","claimedemaildate":"2023-03-14 14:59:52.000000","initials":"DL","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Nadav Askari","email":"nadav@genetikaplus.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkLDF9fwKDA","bounced":false,"claimed":0,"founder":0,"urlname":"nadav-askari","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQ0PKb7woM","position":"CTO","last_name":"Askari","claimtoken":"WAysxJlBsQRSYJ7SzdnimMd0G6SZ6Tn3zpy1mH5upF677lYVf67LF1","first_name":"Nadav","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/nadav-askari/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-03-14 14:59:54.000000","initials":"NA","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGylJ0IDA","fullname":"Natalia Golczar"},"biverifydate":"2020-04-26T00:00:00.000Z","crunchbaseid":"genetika","lastupdator":"Matan Eblagon","lastupdator_email":"matane@sncentral.org","creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2018-07-10T00:00:00.000Z","biverification":"Natalia Golczar","sectorverification":"Yanina Wainscheinker","affiliatedOrganizations":null,"timeline":[{"id":"FSjMnjss7FwlURwwuy9wIPm1qxGiIfuh7YwrDZBu2KBEhX5PBnmpv8","date":"Jun 2024","amount":"$10M","source":"https://www.prnewswire.com/il/news-releases/neurokaire-secures-10-million-to-advance-precision-medicine-for-mental-health-302333663.html","eventtype":"FundingRoundEvent","investment":[{"name":"GreyBird Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/greybird-ventures","logokey":"$YROaGxhp7dZssa4GTF6qwjxPaUYLhSoJEVsTdVvYef4YtIwFDFl76g","tagline":"","urlname":"/investor_page/greybird-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCwlP6UCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"YnX34HNHV2xFDTJHRpEWI7IeMsQrqe6h3sPMNCcYYE5wNFwWyMtd7a","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YROaGxhp7dZssa4GTF6qwjxPaUYLhSoJEVsTdVvYef4YtIwFDFl76g","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":"Follow on&nbsp;"},{"name":"Jumpspeed Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/jumpspeed-ventures","logokey":"$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","tagline":null,"urlname":"/investor_page/jumpspeed-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7HiIgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3tgknLsAKQkvIteMXzBbdlOmcWrHUExym4LKCLdiM2oAZHaL0zzNJf","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Meron Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/meron-capital","logokey":"$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","tagline":null,"urlname":"/investor_page/meron-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwNWayJkLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"FHJ3jyI2wrw37ir8OTARLp2c7TMwnMlaOJKFc5U6P9x7thS5D99lmj","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"0Dgmay2aWSwLNWJHpSG2rDNewuVXd3KA9oZSez7taOEpx0NTUhIpCb","date":"Sep 2022","amount":"$2.5M","source":"","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"European Union’s EIC Fund","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/european-union-s-eic-fund","logokey":"$YQ0gYHbpMvoHMJK34CJyZLAnMytLrGyCRJXaSFKy48bQ3iBkItVyxf.jpeg","tagline":"Venture investment arm of the European Innovation Council (EIC)","urlname":"/investor_page/european-union-s-eic-fund","isisraeli":null,"investorid":"gM7CnZw0FHNRRtctbPzcqLZCnyeov2vhQ7YjNEaQIno94hVdbTkGeQ","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6VEpmq9AP9Maje9vVkF8MsoT2yXWrYd3NRfiC2qQ6kjOeqlRThvQAL","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YQ0gYHbpMvoHMJK34CJyZLAnMytLrGyCRJXaSFKy48bQ3iBkItVyxf.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":2500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDg_q6LCgw","date":"Sep 2021","amount":"$10M","source":"https://www.prweb.com/releases/genetika_a_pioneer_in_personalized_medicine_for_psychiatry_raises_10_million_in_an_oversubscribed_series_a/prweb18227293.htm","eventtype":"FundingRoundEvent","investment":[{"name":"GreyBird Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/greybird-ventures","logokey":"$YROaGxhp7dZssa4GTF6qwjxPaUYLhSoJEVsTdVvYef4YtIwFDFl76g","tagline":"","urlname":"/investor_page/greybird-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCwlP6UCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5eab5b94-3a77-4dd1-b091-ffa6318286a1","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YROaGxhp7dZssa4GTF6qwjxPaUYLhSoJEVsTdVvYef4YtIwFDFl76g","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Michael Zeisser","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/michael-zeisser","logokey":"$8ZDSHo2cQlcwY4zCU8n0ZwT1lQwG4eNGXtVJkZM4S2qmB7qjXKgiKV","tagline":"","urlname":"/investor_page/michael-zeisser","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCQ9JqLCQw","fundingtype":"Angel","leadpartner":null,"investmentid":"129c6060-e036-453a-95dd-d74caf14d049","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8ZDSHo2cQlcwY4zCU8n0ZwT1lQwG4eNGXtVJkZM4S2qmB7qjXKgiKV","leadcaption":"","followupcaption":""},{"name":"Howard Morgan","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/howard-morgan","logokey":"$AHp6ReurYRWeOH29WshxTkuZuhK3TNMTU0D2J8Kir5BYY41H0umIol","tagline":"Co-founder, First Round Capital","urlname":"/investor_page/howard-morgan","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE6oqxCww","fundingtype":"Angel","leadpartner":null,"investmentid":"4da950e1-9da7-4d6c-8301-20819c5c4ce1","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$AHp6ReurYRWeOH29WshxTkuZuhK3TNMTU0D2J8Kir5BYY41H0umIol","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Meron Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/meron-capital","logokey":"$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","tagline":null,"urlname":"/investor_page/meron-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwNWayJkLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"4e6eae4e-b7d0-4197-ab89-2b6f6ea27182","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Jumpspeed Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/jumpspeed-ventures","logokey":"$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","tagline":null,"urlname":"/investor_page/jumpspeed-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7HiIgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"91783ac5-e7cd-4d67-bd6d-9b3e5a6b01cc","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"e2c46991-bb9f-48ab-b986-f37318c81d2b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCxr73HCAw","date":"Jul 2020","amount":"$1M","source":"A post in the company's LinkedIn channel - see notes","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"37961058-adec-49e1-b347-48e4ff4b10f5","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmeOKCgw","date":"Mar 2019","amount":"$580K","source":"Added by Talia Cohen Solal","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority","type":"Government","amount":580000,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"04192de8-efc7-404f-a8ec-e5aad9b2d798","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":580000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEyP3DCAw","date":"Nov 2018","amount":"$40K","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":null,"type":null,"amount":0,"hidden":false,"country":"Israel","fullurl":null,"logokey":null,"tagline":null,"urlname":null,"isisraeli":null,"investorid":null,"fundingtype":"Angel","leadpartner":null,"investmentid":"8bd8a103-caf0-46ed-9791-4f80ce2ba807","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/empty-state.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":40000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkiZW4CAw","date":"Oct 2018","amount":"$1.15M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Jumpspeed Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/jumpspeed-ventures","logokey":"$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","tagline":null,"urlname":"/investor_page/jumpspeed-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7HiIgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"1373de36-e39e-472c-863c-8b02c72b21fe","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","leadcaption":"","followupcaption":""},{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"38113313-6e5c-431a-acb1-0c9036f1a3fe","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","leadcaption":"","followupcaption":""},{"name":"Howard Morgan","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/howard-morgan","logokey":"$AHp6ReurYRWeOH29WshxTkuZuhK3TNMTU0D2J8Kir5BYY41H0umIol","tagline":"Co-founder, First Round Capital","urlname":"/investor_page/howard-morgan","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE6oqxCww","fundingtype":"Angel","leadpartner":null,"investmentid":"9443f05e-0c53-43d4-8d78-5ed5e9d765d0","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$AHp6ReurYRWeOH29WshxTkuZuhK3TNMTU0D2J8Kir5BYY41H0umIol","leadcaption":"","followupcaption":""},{"name":"Meron Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/meron-capital","logokey":"$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","tagline":null,"urlname":"/investor_page/meron-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwNWayJkLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"9a2c0ce3-c889-4b88-bbda-610802081a2d","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","leadcaption":"","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"b8f1c73c-853b-421f-9c2f-d7f022e7a00f","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Private","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1150000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"lU6FkbNCutY0jDBXczBd77ggQ2EwccvzHwANHChuXSk8Fuzig0ZcAO","hub":"BioGiv","date":"","batch":"","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NyEhJIKDA","source":"","enddate":"","hub_type":"Entrepreneurship Program","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/program_page/biogiv","hub_logokey":"$s6g12I1QNPxaMzuKNWZSQjc4FOWLALyqm22Yc3vZTNkPsRlmvrNqM0","hub_urlname":"/program_page/biogiv","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$s6g12I1QNPxaMzuKNWZSQjc4FOWLALyqm22Yc3vZTNkPsRlmvrNqM0","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"8/2018","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"NeuroKaire ","logourl":"https://storage.googleapis.com/clean-finder-353810/$X7rjz3qqbnCzXoxbvFdtpiwGamNYWXTRw9VVnTtRruIvnNwl9Ayo9h.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$X7rjz3qqbnCzXoxbvFdtpiwGamNYWXTRw9VVnTtRruIvnNwl9Ayo9h.jpeg","seoabout":"NeuroKaire (formerly Genetika+) is developing a personalized medical testing tool to better treat depression by helping physicians find the best drug thera...","seoTitle":"Israeli Startup","solutions":[{"title":"Healthcare","description":"NeuroKaire offers an AI-powered digital platform for clinicians to remotely monitor, manage, and provide personalized care for patients with neurological conditions, such as Parkinson's disease, by tracking symptoms, medication adherence, and delivering objective insights.","items":[{"name":"Revenue Growth","value":3,"titleTooltip":"Revenue Growth & Profitability","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Operational Efficiency","value":4,"titleTooltip":"Operational Excellence & Efficiency","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Customer Acquisition","value":4,"titleTooltip":"Customer Acquisition, Satisfaction & Loyalty","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Risk Mitigation","value":3,"titleTooltip":"Risk Mitigation & Business Resilience","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Talent Development","value":3,"titleTooltip":"Talent Development & Employee Empowerment","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Agility & Innovation","value":4,"titleTooltip":"Strategic Agility & Innovation","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}}]},{"title":"Biopharma","description":"NeuroKaire's StemifAi is an AI-driven platform designed to accelerate drug discovery and development for neurological disorders, optimizing R&D processes, improving clinical trial success rates, and reducing costs.","items":[{"name":"Revenue Growth","value":4,"titleTooltip":"Revenue Growth & Profitability","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Operational Efficiency","value":5,"titleTooltip":"Operational Excellence & Efficiency","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}},{"name":"Customer Acquisition","value":3,"titleTooltip":"Customer Acquisition, Satisfaction & Loyalty","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Risk Mitigation","value":4,"titleTooltip":"Risk Mitigation & Business Resilience","meterTooltip":{"title":"Transformative / Strategic","content":"Fundamental, high-value enhancement with far-reaching strategic importance."}},{"name":"Talent Development","value":3,"titleTooltip":"Talent Development & Employee Empowerment","meterTooltip":{"title":"Substantial / Core","content":"Clear, significant contribution; broad, tangible gains."}},{"name":"Agility & Innovation","value":5,"titleTooltip":"Strategic Agility & Innovation","meterTooltip":{"title":"Disruptive / Paradigm-Shifting","content":"Revolutionary, industry-leading change that sets new benchmarks and norms."}}]}],"teamMembersNumber":4,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Medical Diagnostics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Digital Medical Diagnostics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Digital Medical Diagnostics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Medical Decision Support#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Machine Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Digital Medical Diagnostics","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Digital Medical Diagnostics"},{"title":"Medical Decision Support","key":"0-0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Medical Decision Support"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Patients","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"},{"title":"Providers","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]},{"title":"Life Sciences","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-1-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence","children":[{"title":"Machine Learning","key":"0-0-0","path":"TechnologyClassificationModel>Artificial Intelligence>Machine Learning"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Digital Medical Diagnostics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvnms8LDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Decision Support","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iety7cLDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Machine Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu81fgLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Digital Medical Diagnostics","Medical Decision Support"],"coreTechnology":["Artificial Intelligence","Machine Learning"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Patients","Providers","Life Sciences","Pharmaceuticals"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"FSjMnjss7FwlURwwuy9wIPm1qxGiIfuh7YwrDZBu2KBEhX5PBnmpv8","date":"Jun 2024","amount":"$10M","source":"https://www.prnewswire.com/il/news-releases/neurokaire-secures-10-million-to-advance-precision-medicine-for-mental-health-302333663.html","eventtype":"FundingRoundEvent","investment":[{"name":"GreyBird Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/greybird-ventures","logokey":"$YROaGxhp7dZssa4GTF6qwjxPaUYLhSoJEVsTdVvYef4YtIwFDFl76g","tagline":"","urlname":"/investor_page/greybird-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCwlP6UCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"YnX34HNHV2xFDTJHRpEWI7IeMsQrqe6h3sPMNCcYYE5wNFwWyMtd7a","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YROaGxhp7dZssa4GTF6qwjxPaUYLhSoJEVsTdVvYef4YtIwFDFl76g","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":"Follow on&nbsp;"},{"name":"Jumpspeed Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/jumpspeed-ventures","logokey":"$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","tagline":null,"urlname":"/investor_page/jumpspeed-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7HiIgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"3tgknLsAKQkvIteMXzBbdlOmcWrHUExym4LKCLdiM2oAZHaL0zzNJf","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Meron Capital","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/meron-capital","logokey":"$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","tagline":null,"urlname":"/investor_page/meron-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwNWayJkLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"FHJ3jyI2wrw37ir8OTARLp2c7TMwnMlaOJKFc5U6P9x7thS5D99lmj","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDg_q6LCgw","date":"Sep 2021","amount":"$10M","source":"https://www.prweb.com/releases/genetika_a_pioneer_in_personalized_medicine_for_psychiatry_raises_10_million_in_an_oversubscribed_series_a/prweb18227293.htm","eventtype":"FundingRoundEvent","investment":[{"name":"GreyBird Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/greybird-ventures","logokey":"$YROaGxhp7dZssa4GTF6qwjxPaUYLhSoJEVsTdVvYef4YtIwFDFl76g","tagline":"","urlname":"/investor_page/greybird-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCwlP6UCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5eab5b94-3a77-4dd1-b091-ffa6318286a1","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YROaGxhp7dZssa4GTF6qwjxPaUYLhSoJEVsTdVvYef4YtIwFDFl76g","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Michael Zeisser","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/michael-zeisser","logokey":"$8ZDSHo2cQlcwY4zCU8n0ZwT1lQwG4eNGXtVJkZM4S2qmB7qjXKgiKV","tagline":"","urlname":"/investor_page/michael-zeisser","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJCQ9JqLCQw","fundingtype":"Angel","leadpartner":null,"investmentid":"129c6060-e036-453a-95dd-d74caf14d049","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$8ZDSHo2cQlcwY4zCU8n0ZwT1lQwG4eNGXtVJkZM4S2qmB7qjXKgiKV","leadcaption":"","followupcaption":""},{"name":"Howard Morgan","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/howard-morgan","logokey":"$AHp6ReurYRWeOH29WshxTkuZuhK3TNMTU0D2J8Kir5BYY41H0umIol","tagline":"Co-founder, First Round Capital","urlname":"/investor_page/howard-morgan","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE6oqxCww","fundingtype":"Angel","leadpartner":null,"investmentid":"4da950e1-9da7-4d6c-8301-20819c5c4ce1","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$AHp6ReurYRWeOH29WshxTkuZuhK3TNMTU0D2J8Kir5BYY41H0umIol","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Meron Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/meron-capital","logokey":"$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","tagline":null,"urlname":"/investor_page/meron-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwNWayJkLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"4e6eae4e-b7d0-4197-ab89-2b6f6ea27182","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Jumpspeed Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/jumpspeed-ventures","logokey":"$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","tagline":null,"urlname":"/investor_page/jumpspeed-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7HiIgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"91783ac5-e7cd-4d67-bd6d-9b3e5a6b01cc","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"e2c46991-bb9f-48ab-b986-f37318c81d2b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkiZW4CAw","date":"Oct 2018","amount":"$1.15M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Jumpspeed Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/jumpspeed-ventures","logokey":"$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","tagline":null,"urlname":"/investor_page/jumpspeed-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP7HiIgKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"1373de36-e39e-472c-863c-8b02c72b21fe","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$tFb1fciij2V2v33gSw6arLRmMA5ylFpztiZulKBmUK9F8wxiNeMM3r","leadcaption":"","followupcaption":""},{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"38113313-6e5c-431a-acb1-0c9036f1a3fe","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","leadcaption":"","followupcaption":""},{"name":"Howard Morgan","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/howard-morgan","logokey":"$AHp6ReurYRWeOH29WshxTkuZuhK3TNMTU0D2J8Kir5BYY41H0umIol","tagline":"Co-founder, First Round Capital","urlname":"/investor_page/howard-morgan","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE6oqxCww","fundingtype":"Angel","leadpartner":null,"investmentid":"9443f05e-0c53-43d4-8d78-5ed5e9d765d0","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$AHp6ReurYRWeOH29WshxTkuZuhK3TNMTU0D2J8Kir5BYY41H0umIol","leadcaption":"","followupcaption":""},{"name":"Meron Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/meron-capital","logokey":"$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","tagline":null,"urlname":"/investor_page/meron-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwNWayJkLDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"9a2c0ce3-c889-4b88-bbda-610802081a2d","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3w8nw5WhsnXvv2QFMoiLuUzeJSnoClCejaUvi8wRrmc00wSR5YTUB0","leadcaption":"","followupcaption":""},{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"b8f1c73c-853b-421f-9c2f-d7f022e7a00f","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Private","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1150000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"0Dgmay2aWSwLNWJHpSG2rDNewuVXd3KA9oZSez7taOEpx0NTUhIpCb","date":"Sep 2022","amount":"$2.5M","source":"","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"European Union’s EIC Fund","type":"Investor","amount":null,"hidden":false,"country":"Europe","fullurl":"/investor_page/european-union-s-eic-fund","logokey":"$YQ0gYHbpMvoHMJK34CJyZLAnMytLrGyCRJXaSFKy48bQ3iBkItVyxf.jpeg","tagline":"Venture investment arm of the European Innovation Council (EIC)","urlname":"/investor_page/european-union-s-eic-fund","isisraeli":null,"investorid":"gM7CnZw0FHNRRtctbPzcqLZCnyeov2vhQ7YjNEaQIno94hVdbTkGeQ","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"6VEpmq9AP9Maje9vVkF8MsoT2yXWrYd3NRfiC2qQ6kjOeqlRThvQAL","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YQ0gYHbpMvoHMJK34CJyZLAnMytLrGyCRJXaSFKy48bQ3iBkItVyxf.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":2500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCxr73HCAw","date":"Jul 2020","amount":"$1M","source":"A post in the company's LinkedIn channel - see notes","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"37961058-adec-49e1-b347-48e4ff4b10f5","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmeOKCgw","date":"Mar 2019","amount":"$580K","source":"Added by Talia Cohen Solal","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"Israel Innovation Authority","type":"Government","amount":580000,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"04192de8-efc7-404f-a8ec-e5aad9b2d798","fundingsubtype":"","investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":580000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEyP3DCAw","date":"Nov 2018","amount":"$40K","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":null,"type":null,"amount":0,"hidden":false,"country":"Israel","fullurl":null,"logokey":null,"tagline":null,"urlname":null,"isisraeli":null,"investorid":null,"fundingtype":"Angel","leadpartner":null,"investmentid":"8bd8a103-caf0-46ed-9791-4f80ce2ba807","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/empty-state.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":40000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}